Gluten-free (GF) foods, whose claim compliance is controlled at the 'serving level', hold better chances of protecting gluten-intolerant consumers. This is particularly true for GF oatmeal, as oats are easily contaminated with gluten-rich kernels of wheat, rye and barley, which remain intact to the spoon as pill-like flakes. A single contaminant kernel in otherwise pure oats results in GF labelling noncompliance, thereby posing a risk to patients with coeliac disease. Our in-market survey of 965 GF oatmeal servings uncovered that one in fifty-seven servings exceeded the GF labelling maximum of 20 mg kg À1 (i.e. 20 ppm). The noncompliance pattern was 'binary-like', with kernel-based contamination the suspected pass/fail driver.
Introduction
Coeliac disease (CD) is a lifelong, genetic, autoimmune intestinal disorder that affects approximately 0.2-1.0% of the world population (Sanders et al., 2003; Catassi & Fasano, 2008; Mustalahti et al., 2010; Ludvigsson et al., 2013; Mooney et al., 2016) . Patients with CD have to abstain from dietary intake of gluten proteins found in wheat, barley and rye, as these proteins trigger autoimmune destruction of the mucosa of the small intestine (Janatuinen et al., 1995) . Members of a household that includes a patient with CD often choose to follow a GF diet as well, to avoid accidental consumption of gluten-containing food by the patient with CD. Increased numbers of consumers are also choosing to follow a GF diet (Sharma et al., 2015) . As a consequence, GF food products are getting more popular in the marketplace (Sapone et al., 2012) . To protect this growing number of consumers, food regulatory agencies have started to regulate gluten content in products with GF claims. For example, the US Food and Drug Administration (FDA) has decided that foods with GF claims should contain less than 20 ppm (i.e. mg kg À1 ) of gluten (Sharma et al., 2015) . This has elevated the need for improved methodologies to determine whether grain-based product meets this standard. Oats are recognised as one of the most important whole grain foods, being rich in dietary fibre, B-complex vitamins (thiamin, niacin and riboflavin), iron and proteins (Comino et al., 2015; Rebello et al., 2016) . To expand the dietary options of patients with CD, as well as those following a GF diet, many researchers have investigated the suitability of dietary inclusion of oats (Lundin et al., 2003; Thompson, 2003; Comino et al., 2011 Comino et al., , 2015 Londono et al., 2013; Tapsas et al., 2014) . Although there has been debate whether oats present risks to patients with CD (Comino et al., 2011 (Comino et al., , 2015 Londono et al., 2013) , increasing amounts of clinical data show that most patients with CD can tolerate dietary intake of oats (Lundin et al., 2003; Thompson, 2003; Tapsas et al., 2014) . Therefore, inclusion of pure oats in a GF diet is considered safe (Janatuinen et al., 1995; Lundin et al., 2003; Thompson, 2003; Tapsas et al., 2014) and viewed as a way to expand dietary options and improve nutritional status of GF conscious consumers (Comino et al., 2015) .
Pure oats, which are free of any nonoat cereal contaminants, are not easy to obtain though, as gluten-containing kernels of wheat, rye and barley can easily cross-contaminate oats in the field, during transport, in storage and during processing (Thompson, 2004; Hernando et al., 2008; Thompson et al., 2010; Koerner et al., 2011) . These contaminant kernels act as 'pill-like' pockets of gluten, interspersed throughout otherwise GF pure oats. Removal of these contaminant kernels appears to be a straightforward way to produce GF product. However, if not effectively mitigated, these gluten 'pills' will be transformed into flakes, ultimately ending up in a pouch or comparable serving size. Consumption of such a serving presents a realistic risk to gluten-intolerant consumers, especially patients with CD. Because of this, it is felt that GF oatmeal claim compliance should be managed at the serving size level, as it holds a better chance to protect consumers from this form of kernel-based gluten contamination (than does assessing compliance at a 'higher' level like at the tote or batch level).
So, kernel-based contamination by its nature sets up a binary set of gluten test outcomes at the serving size evaluation level. One possible outcome is zero gluten in pure oats, and the other is high gluten in a kernel contaminated serving. This pass/fail circumstance highlights the need for a sampling approach tuned to this defect pattern. This contrasts with the use of 'variables' sampling, which assumes a continuous possible range of gluten content, serving to serving, and which may be subtly (and unintentionally) implied by the gluten regulatory threshold of 20 mg kg À1 , as this (or ('parts per million') is a continuous variable, appropriate for many nonwhole kernel GF foods, but not for those vulnerable to kernel-based contamination such as whole grain oat products.
We have investigated the dynamics and consequences of kernel-based gluten contamination in GF oatmeal herein, starting with the state of affairs of GF labelling compliance of GF oatmeal in the US market. The survey suggests shortcomings exist with producer outgoing quality inspection. This may be driven by an under appreciation of the subtle but important effects that kernel-based gluten contamination impose on process and lot acceptance sampling ability. The discussion is supplemented with probabilities of detection for various 'serving noncompliance rates' relative to the number of servings evaluated. We also provide guidelines, which prescribe sampling quantities to ensure with high confidence that various rates of nonconformance are not exceeded.
Materials and methods

Materials
GF oatmeal was acquired from the US marketplace by a third-party sample acquisition company. The R-Biopharm R5 ELISA RIDASCREEN Gliadin (R7001) kit was used for analyses, being purchased from R-Biopharm, Inc. (Washington, MO, USA).
Sample collection and gluten analysis for in-market survey
The GF oatmeal products acquired were produced by two large US producers and acquired from US store shelves by a third-party sample acquisition company. The identification of the brand names and producers on the packages were masked by the sample acquisition company and relabelled with sample numbers for subsequent tracking purposes. The oatmeal products collected from the market had two types of packages, 45 g in a serving pouch and 2 pounds in a bag. Three hundred and twenty-nine servings (e.g. either serving pouches or all 50-g oatmeal servings from a bag) were gathered in July 2014 and analysed at PepsiCo analytical laboratory. Before analysing the market survey samples though, a fit-for-purpose single laboratory validation of R-Biopharm R5 ELISA RIDASCREEN Gliadin (R7001) method was performed in our internal analytical laboratory. This was following the guideline provided by AOAC Official Method of Analysis, Appendix M. Accuracy and precision of the method both met the corresponding requirements listed AOAC Official Method Official Method of Analysis, Appendix M. The accuracy and precision values will not be disclosed because they are proprietary information. An additional six hundred thirty-six servings were then gathered in December 2014 and analysed at a well-recognised thirdparty laboratory with accreditation to ISO/IEC 17025:2005, which covers gluten ELISA analysis. We did not perform a multilaboratory gluten method validation due to the time strain on our research. However, before analysis of our in-market survey samples, split samples had been tested by the third-party contract analytical laboratory and PepsiCo analytical laboratory. No significant differences were found between these two laboratories. Each of the 965 servings (45 g directly from a serving pouch or every 50 g weighed out from 2-pound packages) was individually ground for 2 min using a magic bullet food processor (PepsiCo analytical laboratory), or a Kitchen Aid coffee grinder (third-party analytical laboratory). A clean grinding head and sample cup were used to grind each serving. Gluten extraction cocktail (R-Biopharm, R7006) was used to extract gluten from 0.25 g of each ground serving, and R-Biopharm R5 ELISA RIDASCREEN Gliadin kit (R7001) was used by both laboratories for gluten analyses. Only one 0.25 g of sample was tested for gluten for each ground serving. All analyses were conducted according to the manufacturer's instructions.
Statistical analysis
Data analysis was performed by custom macros using Excel, Microsoft Office 2013. Statistical significance was calculated at 95% confidence.
Results and discussion
In-market survey of GF oatmeal
The 'in-market' assessment of GF labelled oatmeal was conducted from July through December, 2014. Nine hundred and sixty-five servings (~45-50 g per serving) were acquired from store shelves. These were from two well-known US producers and spanned twenty-one different date codes. The number of servings obtained per date code varied from a low of ten up to a maximum of 108 servings.
The survey had two parts, divided by time and laboratory. The first was comprised of 329 servings acquired in the summer of 2014. All of these samples were tested at our internal analytical laboratory. This is referred to as the '7/14 Assessment' ( Table 1 ). The second part was comprised of 636 additional servings acquired late 2014. These samples were tested at a recognised external laboratory. This is referred to as the '12/14 Assessment' ( Table 1) . The focus of our in-market survey was to examine whether the tested samples were in compliance with FDA gluten regulation (<20 mg kg -1 ). So, once we knew the gluten content of a sample was above or below 20 ppm, we did not do further analysis. That was the reason that we did not further dilute sample extracts with >80 ppm readings (upper limit of the quantification curve of R-Biopharm R7001 ELISA kit) to obtain the exact gluten contents ( Fig. 1 and Table 1 ).
The 965 total servings were acquired to characterise the overall state of affairs of GF oatmeal labelling compliance at the serving size level and to gain insight into differences/biases that exist between laboratories, time frames and producers. In this latter regard, statistical comparisons were made via chi-square contingency tests between laboratories/time frames ('7/14' vs. '12/14'), between producers ('Producer 1' vs. 'Producer 2'), between the two time frames for each producer (Producer 1 '7/14' vs. Producer 1 '12/14' and Producer 2 '7/14' vs. Producer 2 '12/14') and between date codes. No 'statistically significant' differences in 'proportion of servings found noncompliant' were found. Consequently, based on this data set, no evidence was found that the noncompliance rate at the serving size level differed between these two laboratories/time frames, producers or date codes.
As Table 1 shows, about 95% of the 965 servings were found to have a gluten content below the limit of quantification (BLQ) of the gluten testing kit, R-Biopharm 7001 (i.e. <5 ppm). It is worth mentioning that BLQ results do not equate to true zero results (and as gluten testing methodologies evolve, lower BLQ levels will no doubt be achieved). Continuing, 3.21% were found to be gluten positive but compliant, namely having a gluten content from 5 to <20 ppm, and 1.76% were found noncompliant, with a gluten content of ≥20 ppm. Additionally, 0.62% of the 965 were found >80 ppm, which is the quantification limit (ALQ) of the gluten testing kit. This equates to about one in every fifty-seven servings exceeding the FDA defined Bold values indicate % servings noncompliant.
labelling limit, and one in 161 being greater than four times that level. Across the 965 servings, the overall average gluten is calculated to be 1.18 ppm per serving (i.e. 1.18 mg kg À1 per serving). This is assuming 0 mg kg À1 for BLQs and 80 mg kg À1 for ALQs. However, only forty-eight of the 965 servings contain any measurable gluten. Of those, if one conservatively assumes an AQL reading as 80 ppm, seventeen contain about 71% of total gluten observed, averaging about 48 ppm (so, about one in fifty-seven servings at this level).
It is important to note that the above referenced results were all single test outcomes per serving. Our recent research has shown that when a gluten-containing kernel exists in a serving of oatmeal, a single test result can underestimate overall serving gluten content (Fritz et al., 2017) . This is because gluten from the contaminate kernel tends to end up lognormally distributed in the ground sample (even with grinding performed under current best grinding practices). In other words, much of the gluten from the contaminant kernel remains concentrated in a few pockets within the serving after grinding, not being well dispersed. So consequently, a small test amount, randomly selected from the serving, is more likely than not to undercount overall gluten. With this insight, it was found that for samples initially testing 'gluten positive yet compliant' (i.e. 5 to <20 ppm), when ten additional tests per sample were conducted, about half ended up averaging noncompliant, that is ≥20 ppm (Fritz et al., 2017) . It is fair to assume that additional tests (beyond ten per serving for this 'positive yet compliant' group) could provide higher proportions of samples averaging >20 ppm, due to the lognormal distribution of gluten in these already deemed 'gluten-positive' ground samples. Figure 1 provides a graphical depiction of the gluten distribution observed in the survey. It shows both the single test per serving outcomes and the assumed more accurate distribution if initially found 'positive yet compliant outcomes' were subjected to multiple tests per serving (using 50% of 5 to <20 ppm servings ending up in the 20-80 ppm category due to this).
The overall gluten per serving circumstance uncovered, that is where most servings measure BLQ and then are interspersed with occasional noncompliant servings, holds at the 'date code' level as well. Of the thirteen of twenty-one date codes possessing noncompliant servings, the maximum noncompliant serving rate was also 5% (like the overall data set). This maximum rate was not found statistically different from any other date code outcomes.
So it appears a bimodal-like noncompliance pattern (in terms of ppm) has been revealed in the GF oatmeal marketplace in terms of gluten per serving, where numerous BLQ servings are 'interrupted' by occasional noncompliant ones, some being several times the regulatory limit. These results indicate the GF oatmeal production processes of these two producers do not have sufficient capability to effectively mitigate gluten contamination to BLQ at the serving size level. The pattern of defects supports the premise that kernelbased gluten contamination is the cause, which produces high levels of gluten in oatmeal servings made from otherwise GF, pure oats. The outcomes encountered also suggest the inspection regimens used to assess overall process capability and lot acceptance are incapable of detecting the level of noncompliance observed.
This binary-like noncompliance pattern sheds light on interpretation of what some might view errantly as an attractive 1.18 ppm gluten average/serving found across these 965 servings. But despite a low ppm average per serving, the gluten is obviously not well dispersed across them (as an average errantly implies), but rather resides concentrated in a handful of servings, many being noncompliant in regard to GF labelling requirements.
The above survey insight has served as the genesis for this work, guiding the balance of the investigation. Estimation of a wheat kernel's contribution to gluten content in pure oats
As mentioned, gluten-containing kernels of wheat, barley and rye are the predominant source of gluten contamination in oats (Thompson, 2004; Hernando et al., 2008; Thompson et al., 2010; Koerner et al., 2011) . If not effectively mitigated, these kernel contaminants will survive the oatmeal production process intact (possibly being cut) and ultimately appear in a serving as indistinguishable flakes, consumed unknowingly by GF conscious consumers. Using wheat as an example, we have estimated the gluten contribution from a single kernel in a typical serving size of 40 g of otherwise pure oats (Table 2) . This is based on 'literature reported' wheat protein content (2015 Crop Quality Report by US Wheat Associates, http://www.uswheat.org/cropQuality) and wheat gluten content (Shewry, 2009) . We found that for the six predominant North American wheat varieties, a single wheat kernel will bring on average 65-129 mg kg À1 of gluten to 40 g of pure oats. This estimation suggests that gluten kernel contaminants, including a cut or broken kernel, can lead to noncompliance at a serving size level, thereby posing a risk to GF oatmeal consumers.
Sampling implications in assessment of kernel-based gluten contamination
The binary-like circumstance of gluten outcomes creates a sampling context similar to a pass/fail one. A serving fails when a gluten kernel or part of one exists in a serving, leading to noncompliance relative to gluten regulatory thresholds (e.g. >20 ppm by FDA), and passes when one does not. 'Attribute'-based sampling caters to binary type outcomes like this (Taylor, 1992) . This type of sampling is in contrast to 'variable sampling', which assumes a few samples can provide information about the others around them. A key prerequisite for variable sampling therefore is the ability to pick a sample that is 'representative' of the rest (Taylor, 1992) . The kind of distribution uncovered in this survey (Fig. 1) complicates doing so however, as randomly selecting some servings for analysis may not adequately provide a representative inference on the rest.
To investigate this, a sampling simulation was conducted where 10 000 samples of five, ten, twenty-five and fifty servings each were generated by randomly 'selecting' outcomes from the distribution of the 965 outcomes from the survey. Doing so, it was found that the probability of all servings selected being found compliant was 0.92, 0.84, 0.64 and 0.41 for samples of five, ten, twenty-five and fifty servings, respectively. So, with fifty servings evaluated for instance, about 40% of the time one will not get an indication of a compliance problem, getting all compliant outcomes. This probability increases when fewer servings are evaluated. So, with an underlying noncompliance rate of about one in fiftyseven servings, with~1 in 161 being more than four times the regulatory maximum, sampling quantities in this range can fail to detect (with high confidence) inherent process and lot acceptance incapability. This is believed due to underlying statistical inferences that are being relied upon, which are undermined by the binary type distribution which kernel-based gluten contamination has been shown to cause. Table 3 expands on this, showing the probability of selecting a contaminated serving in one to fifty tries for various rates of contamination present. This table is built on binomial distribution probabilities for pass/ fail type outcomes (i.e. attribute-based sampling) and further shows how noncompliance can go undetected for a time when modest sampling efforts are employed. When nonconformance rates are as high as one in ten servings, examination of five servings under this scenario provides less than a 50/50 chance of randomly selecting a serving that contains a gluten kernel.
Attribute-based sampling guidelines
Sampling required to avoid this risk is also shown in Table 3 . In the right most column are sample sizes required to gain high confidence (i.e. 95% in this case) that various 'kernel-induced gluten noncompliance' rates are not being exceeded. These were derived using the same 'attribute-based acceptance sampling' as before (Taylor, 1992) . These are large quantities, especially in comparison with continuous variable-based sampling, but provide high statistical confidence that products subject to 'kernel-based gluten' contamination are clean enough to be labelled gluten free. For example, to affirm that the 'serving noncompliance rate' (i.e. rate of servings containing a gluten-containing kernel) is no greater than one in every 1000 servings with 95% confidence, one would have to look at 2994 servings and find them all clean to make that claim, doing so for a 'rationally defined' production lot. By 'rationally defined' is meant a lot that is relatively consistent in terms of the rate of kernel-based contamination, as might happen with oats from the same field potentially.
The extent of testing which attribute sampling requires is admittedly onerous, but appears necessary to accurately characterise the inherent capability to produce GF oatmeal at the serving level, and ensure outgoing quality is adequately controlled to protect CD consumers. More cost effective ways to accomplish this are clearly desirable, and research is underway in this direction.
Conclusion
We believe that GF foods, whose claim compliance is controlled at the 'serving level,' hold better chances to protect gluten-intolerant consumers and achieve brand differentiation. In that vein, our research here spotlights how wheat, rye and barley kernels act as 'gluten pills' in oatmeal, remaining intact to the spoon as indistinguishable flakes. And further, how this unique circumstance creates a binary-like set of possible gluten contamination outcomes at the serving level, namely servings with a contaminant kernel (being noncompliant) and those without (being compliant). Our investigation reveals how this situation impacts the sampling/assessment task, as extreme sets of outcomes like this undermine the commonly used sampling techniques of 'looking at a few' to 'draw inferences on the rest.' Findings suggest it prudent to consider a sampling/assessment task oriented towards characterising the 'rate of servings that possess gluten pills' instead of attempting to characterise 'mg kg À1 gluten' that might exist across 'representative' servings. The approach prescribed utilises attribute sampling. With this, one can gain high confidence that unacceptably high rates of gluten kernel contaminated servings are not getting onto store shelves, helping ensure processes are capably robust to the significant effects of kernelbased gluten contamination. But this assurance comes at a price in terms of sampling vigilance required, especially compared to what one could do given a more homogenously dispersed type of contamination like gluten dust or flour.
This situation has relevance as noncompliant gluten-free labelled products have been found on store shelves. This suggests incapable production processes are being viewed as capable, potentially due to this inferential nuance being overlooked. As we have seen, oversight of this can put CD consumers at risk, as they will occasionally ingest noncompliant servings measuring well over the FDA limit. It is the hope of this research to bring awareness, investigation, accounting and research to this subtle but important topic, and by doing so drive improvement towards higher integrity products for the growing gluten conscious marketplace. Furthermore, our consideration of measuring compliance at the serving size level may be instructive across other contamination-free claims in general, where kernel 
